Biotech Values

[Preciouslife1]

Israeli stunning scientific innovation cures diabetic

http://www.weeklyblitz.net/2312/israeli-stunning-scientific-innovation-cures

Two large Israeli drug makers have so far invested more than US$ 50 million in inventing a medicine which is a radically improved weapon against Type 1 diabetes, stopping it at its source. Israeli medicine company Teva Pharmaceutical Industries owns the license and worldwide market rights to DiaPep2777, a trademarked peptide first synthesized in 1994 by Professor Irun Cohen at Israel's Weizmann Institute. This synthetic peptide - a chemical link extracted from a long protein chain - seems to halt the progression of this form of the disease, which used to be called "juvenile" diabetes. Both Type 1 and Type 2 diabetes result from problems with insulin, a hormone produced by the pancreas to convert sugar, starches and other foods into energy for all the body's functions. Type 1, accounting for about five percent of the estimated 220 million worldwide cases of diabetes, is caused by an abnormal immune response that kills the insulin-producing beta cells in the pancreas. Until now, nobody has found a way to address the root cause of this serious immune system foul-up, so patients must take daily injections of insulin ... continued in link above . . .